Skip to content

Commit fc6f859

Browse files
committed
Describe final version of Wave 12
1 parent b423a8e commit fc6f859

File tree

1 file changed

+68
-47
lines changed

1 file changed

+68
-47
lines changed

docs/symptom-survey/coding.md

Lines changed: 68 additions & 47 deletions
Original file line numberDiff line numberDiff line change
@@ -790,6 +790,11 @@ are not anticipated to change the respondent’s answer.
790790
might become seriously ill from CVOID-19?”) was removed.
791791
* Item C17a (“Have you had a seasonal flu vaccination since July 1, 2020?”) was
792792
removed.
793+
* On November 8, 2021, item V2 “How many vaccinations have you received?” was
794+
removed from Wave 11, as the response options did not allow for respondents to
795+
report booster shots and additional doses. Booster doses were becoming more
796+
common at this time, making the lack of booster response options jarring to
797+
respondents.
793798

794799
### Notes
795800

@@ -804,36 +809,42 @@ are not anticipated to change the respondent’s answer.
804809

805810
## Wave 12
806811

807-
Wave 12 was deployed on October 7, 2021. Deployment is in two phases:
812+
Wave 12 was deployed on December 19, 2021, after an experimental phase in
813+
October:
808814

809-
* Initially the survey was given only to 15% of survey respondents, the
810-
remainder receiving Wave 11. This phase lasted until October 22. This phase
811-
was used to conduct three experiments with (1) demographic module placement,
812-
(2) vaccination uptake question, and (3) survey invitation text. Details of
813-
these experiments can be found [below](#experiments). In data files, this is
814-
marked as wave "12.5" to distinguish from the final version.
815-
* After results of the experiments are analyzed, a final version will be
816-
deployed using only one demographic module placement and one vaccine uptake
817-
question. This will be marked as wave 12 in the data files.
815+
* From October 7 to October 22, 2021, an experimental Wave 12 was given only to
816+
15% of survey respondents, the remainder receiving Wave 11. This phase was
817+
used to conduct three experiments with (1) demographic module placement, (2)
818+
vaccination uptake question, and (3) survey invitation text. Details of these
819+
experiments can be found [below](#experiments). In data files, this is marked
820+
as wave "12.5" to distinguish from the final version. Data from the
821+
experimental wave 12 was not included in the aggregates published in the
822+
COVIDcast API or in our [contingency tables](contingency-tables.md).
823+
* After results of the experiments were analyzed, the final version was deployed
824+
on December 19, 2021. In data files, this is marked as wave 12.
818825

819826
Wave 12 is available in English and the languages introduced in Wave 3.
820827

821828
Files:
822829
* [Wave 12 text and coding](waves/CMU Survey Wave 12.pdf) (PDF)
823830
* [Wave 12 text and coding](waves/CMU Survey Wave 12.docx) (Word)
824831

825-
Besides the experiments, Wave 12 revises the schooling module of the survey
832+
Besides the experiments, Wave 12 revised the schooling module of the survey
826833
instrument and adds questions regarding parents’ intention to vaccinate their
827834
children (under age 18). Please review the changes carefully when you use
828835
responses from multiple waves of this survey.
829836

837+
### Demographic Module Placement
838+
839+
In the prior waves of CTIS, respondent demographics were collected towards the
840+
end of the survey. These questions are now asked after the vaccine module of the
841+
survey. This placement was chosen after the [order experiments described
842+
below](#experiments) found that this ordering improved response rates to the
843+
demographic items. We expect this will aid users who need demographic data for
844+
their survey analyses.
845+
830846
### New Items
831847

832-
* Item V1alt asks respondents who they personally know has already received a
833-
COVID-19 vaccine. Response options include themselves, household members, and
834-
others. This is an alternate form of the item capturing vaccine uptake, and is
835-
part of the vaccination uptake question experiment described
836-
[below](#experiments).
837848
* Item P1 asks if the respondent is a parent or legal guardian of a child under
838849
age 18.
839850
* Item P2 asks respondents the age group of their oldest child. This replaces
@@ -847,16 +858,18 @@ responses from multiple waves of this survey.
847858
* Item P6 asks respondent about the preventative measures that apply if their
848859
oldest child is attending any in-person classes. These response options are a
849860
subset of response options from E3 with several new additions.
861+
* In the experimental phase, item V1alt asked respondents who they personally
862+
know has already received a COVID-19 vaccine. Response options include
863+
themselves, household members, and others. This is an alternate form of item
864+
V1 capturing vaccine uptake, and is part of the vaccination uptake question
865+
experiment described [below](#experiments). In the final version of Wave 12,
866+
item V1alt is not used and item V1 remains unchanged.
850867

851868
### Changed Items
852869

853870
* Item B13a asks respondents “Have you ever had coronavirus (COVID-19)?” and
854871
replaces item B13 “As far as you know, have you ever had coronavirus
855872
(COVID-19)?” for ease of translation.
856-
* The vaccination uptake question experiment uses questions V1 and V1alt.
857-
Subsequently, questions that use V1 in the display logic have been updated to
858-
also include respondents who are asked V1alt. The display logic has been
859-
updated for the following questions: V2, V11a, V3a, V5a, V12a, V16, and V9
860873
* Item V5a, V5b and V5c have the following revisions to response options:
861874
* The response option “I don’t like vaccines” was revised to “I don’t like
862875
vaccines generally” to distinguish from a specific dislike of COVID-19
@@ -870,6 +883,10 @@ responses from multiple waves of this survey.
870883
added: “The available appointment locations did not work for me” and “Other”
871884
* Item V15b has two new response options: “The available appointment locations
872885
did not work for me” and “Other”.
886+
* The vaccination uptake question experiment uses questions V1 and V1alt. During
887+
the experiment, questions that use V1 in the display logic were updated to
888+
also include respondents who are asked V1alt. The display logic was updated
889+
for the following questions: V2, V11a, V3a, V5a, V12a, V16, and V9.
873890

874891
### Removed Items
875892

@@ -886,41 +903,45 @@ responses from multiple waves of this survey.
886903

887904
Wave 12 was initially launched to 15% of respondents to collect data for the
888905
experiments described below. (The remaining 85% continued to receive Wave 11.)
889-
After the experiments have been conducted and the data analyzed; the CTIS team
890-
will finalize the Wave 12 instrument to be distributed to the entire sample.
891-
Wave 12 will consist of three experiments with (1) demographic module placement,
892-
(2) vaccination uptake question, and (3) survey invitation text.
906+
This experiment was run from October 7 to October 22, 2021. After the
907+
experiments were conducted and the data analyzed, the CTIS team finalized the
908+
Wave 12 instrument to be distributed to the entire sample. This finalized
909+
version was deployed on December 19, 2021.
910+
911+
The Wave 12 trial phase consisted of three experiments with (1) demographic
912+
module placement, (2) vaccination uptake question, and (3) survey invitation
913+
text.
893914

894915
#### Demographic Module Placement and Vaccine Uptake Question
895916

896-
The 15% of respondents who receive the experimental Wave 12 will be divided into
917+
The 15% of respondents who received the experimental Wave 12 were divided into
897918
three groups:
898919

899-
* Group 1 (5% of respondents) will see the demographics questions after the
900-
symptom module, which concludes with question B2b “For how many days have you
901-
had at least one new or unusual symptom?” This group of respondents will see
902-
the Wave 11 version of the vaccine uptake question (V1).
903-
* Group 2 (5% of respondents) will see the demographics questions after the
904-
COVID vaccine module, which concludes with question V9 “How concerned are you
905-
that you would experience a side effect from a COVID-19 vaccination?” This
906-
group of respondents will see the Wave 11 version of the vaccine uptake
907-
question (V1).
908-
* Group 3 (5% of respondents) will see the experimental form of the vaccination
920+
* Group 1 (5% of respondents) saw the demographics questions after the symptom
921+
module, which concludes with question B2b “For how many days have you had at
922+
least one new or unusual symptom?” This group of respondents saw the Wave 11
923+
version of the vaccine uptake question (V1).
924+
* Group 2 (5% of respondents) saw the demographics questions after the COVID
925+
vaccine module, which concludes with question V9 “How concerned are you that
926+
you would experience a side effect from a COVID-19 vaccination?” This group of
927+
respondents saw the Wave 11 version of the vaccine uptake question (V1).
928+
* Group 3 (5% of respondents) saw the experimental form of the vaccination
909929
uptake question (V1alt), which asks respondents “Do you personally know anyone
910930
who has received the COVID-19 vaccine already?” Response options include
911-
themselves, household members, and others. These respondents will not receive
912-
the previous vaccine uptake question, V1. They will see the demographic
913-
questions in the Wave 11 placement, at the end of Module A/B and before the
914-
occupation questions.
931+
themselves, household members, and others. These respondents did not receive
932+
the previous vaccine uptake question, V1. They saw the demographic questions
933+
in the Wave 11 placement, at the end of Module A/B and before the occupation
934+
questions.
915935

916-
A new column `w12_treatment` in the microdata files will indicate which of the
917-
three groups above each respondent was assigned to.
936+
A new column `w12_treatment` in the microdata files indicates which of the three
937+
groups above each respondent was assigned to.
918938

919939
#### Survey Invitation Text
920940

921-
Our partners at Facebook will also be conducting an experiment among those
922-
allocated to receive Wave 11. Among those participants, 6% will receive will
923-
receive one of six different invitations to the survey on their News Feed. This
924-
will be an internal Facebook experiment conducted with the goal of improving
925-
response rates and exploring additional non-response bias in the weighting
926-
process. More details will be provided when the survey invitation is finalized.
941+
During the Wave 12 experiment period, our partners at Facebook conducted an
942+
experiment among those respondents allocated to receive Wave 11. Among those
943+
participants, 6% will receive will receive one of six different invitations to
944+
the survey on their News Feed. This will be an internal Facebook experiment
945+
conducted with the goal of improving response rates and exploring additional
946+
non-response bias in the weighting process. More details will be provided when
947+
the survey invitation is finalized.

0 commit comments

Comments
 (0)